As noted above, it has been reported that patients with inflammatory autoimmune diseases, such as rheumatoid arthritis or multiple sclerosis, demonstrate a significant decrease in GRK2 level in their PBMCs as compared to healthy controls [12,19,20]. This evidence concerns the gene GRK2 and rheumatoid arthritis.